Nivolumab
Nivolumab (nye vol' ue mab), marketed as Opdivo, is a human IgG4 anti-PD-1 monoclonal antibody used to treat cancer. Nivolumab works as a checkpoint inhibitor, blocking a signal that would have prevented activated T cells from attacking the cancer, thus allowing the immune system to clear the cancer. It was discovered at Medarex, developed by Medarex and Ono Pharmaceutical, and brought to market by Bristol-Myers Squibb (which acquired Medarex in 2009) and Ono.
Nivolumab
Nivolumab (nye vol' ue mab), marketed as Opdivo, is a human IgG4 anti-PD-1 monoclonal antibody used to treat cancer. Nivolumab works as a checkpoint inhibitor, blocking a signal that would have prevented activated T cells from attacking the cancer, thus allowing the immune system to clear the cancer. It was discovered at Medarex, developed by Medarex and Ono Pharmaceutical, and brought to market by Bristol-Myers Squibb (which acquired Medarex in 2009) and Ono.
has abstract
Anti–PD-1 – lek biologiczny o ...... wszej fazie badań klinicznych.
@pl
Le nivolumab est un anticorps ...... utilisé dans certains cancers.
@fr
Nivolumab (nye vol' ue mab), m ...... art, and the digestive system.
@en
نيفولوماب هو جسم مضاد وحيد الن ...... أوبديفو (بالإنجليزية: Opdivo).
@ar
ニボルマブ（Nivolumab、商品名：オプジーボ）は、悪性 ...... が承認され、2014年9月小野薬品工業から発売が開始された。
@ja
ATC prefix
ATC suffix
CAS number
946414-94-4
Wikipage page ID
35,007,537
Wikipage revision ID
745,013,345
ChemSpiderID
molecular weight
synonyms
ONO-4538, BMS-936558, MDX1106
target
tradename
hypernym
comment
Anti–PD-1 – lek biologiczny o ...... wszej fazie badań klinicznych.
@pl
Le nivolumab est un anticorps ...... utilisé dans certains cancers.
@fr
Nivolumab (nye vol' ue mab), m ...... ired Medarex in 2009) and Ono.
@en
نيفولوماب هو جسم مضاد وحيد الن ...... أوبديفو (بالإنجليزية: Opdivo).
@ar
ニボルマブ（Nivolumab、商品名：オプジーボ）は、悪性 ...... が承認され、2014年9月小野薬品工業から発売が開始された。
@ja
label
Anti-PD-1
@pl
Nivolumab
@en
Nivolumab
@fr
نيفولوماب
@ar
ニボルマブ
@ja